ArticlePharmaceuticals (Basel, Switzerland)2026

Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance.

Ricardo Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.